AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 165 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,271,000 | +22.9% | 348,000 | 0.0% | 0.20% | +8.8% |
| Q2 2020 | $2,662,000 | +23.8% | 348,000 | 0.0% | 0.18% | +2.2% |
| Q1 2020 | $2,151,000 | -26.4% | 348,000 | +45.0% | 0.18% | -29.9% |
| Q4 2019 | $2,921,000 | +5.4% | 240,000 | 0.0% | 0.25% | 0.0% |
| Q3 2019 | $2,772,000 | +38.0% | 240,000 | +19.4% | 0.25% | +38.8% |
| Q2 2019 | $2,008,000 | +55.3% | 200,968 | +100.2% | 0.18% | +46.4% |
| Q1 2019 | $1,293,000 | +493.1% | 100,370 | +1293.1% | 0.12% | +28.9% |
| Q4 2015 | $218,000 | -44.0% | 7,205 | -26.5% | 0.10% | -47.6% |
| Q3 2015 | $389,000 | – | 9,800 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
| Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
| Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
| Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
| FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
| AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
| ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
| Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |